NewGenIvf (NIVFW) Gross Margin (2024 - 2025)

NewGenIvf (NIVFW) posted quarterly Gross Margin of 36.79% for Q4 2025, down 555.0% YoY from 8.08% in Q4 2024, and up 299.67% sequentially from 9.2% in Q3 2025.

NewGenIvf (NIVFW) Gross Margin (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Gross Margin across 2 years of filings, most recently posting 36.79% for Q4 2025.

  • In Q4 2025, Gross Margin fell 555.0% year-over-year to 36.79%; the TTM figure through Dec 2025 stood at 33.56% (changed N/A YoY), while the FY2025 annual figure was 20.22%, down 1340.0% from the prior year.
  • Gross Margin climbed to 36.79% in Q4 2025, from 9.2% in the prior quarter.
  • Over the last five years, Gross Margin for NIVFW reached as high as 44.07% in Q3 2024 and fell as low as 9.2% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 85.07%
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 32.82%
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 82.10%
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 31.42%
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 84.75%
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 21.12%
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 71.44%
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 24.35%
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn 74.36%
10 NewGenIvf - - 524,025.00 36.79%

Historic Data

Download Data
DateValue
Dec 31, 2025 36.79%
Sep 30, 2025 9.20%
Dec 31, 2024 42.33%
Sep 30, 2024 44.07%